Skip to main content
. 2021 Apr 26;18:99. doi: 10.1186/s12974-021-02149-4

Fig. 7.

Fig. 7

Suppressive effect of GAT107 on inflammatory cytokine release from PBMCs from HDs and MS patients. PBMCs were purified from samples from human donors, including healthy donors (a, b) and MS patients (c, d), and stimulated with ConA (5 μg/ml) with and without ACh (100 μM) or GAT107 (10 μM) for 24 h. (a + c) IL-17 and (b + d) IL-6 secretion were detected by ELISA (n = 17–19) (*p < 0.05)